6533b827fe1ef96bd128644f

RESEARCH PRODUCT

Short, full-dose neoadjuvant chemotherapy in localized high-risk adult soft tissue sarcomas (STS): An exploratory subgroup analysis on responding patients in a randomized controlled trial comparing 3 neoadjuvant versus 3 neoadjuvant + 2 adjuvant cycles of full dose anthracycline and ifosfamide chemotherapy at a 10yr median FU.

Angelo Paolo Dei TosCarlo MorosiAlessandro GronchiJosefina CruzVittorio QuagliuoloGiovanni GrignaniAntonio Llombart-boschAlessandro ComandoneSara PizzamiglioJavier Martin BrotoSilvia StacchiottiPaolo G. CasaliPiero PicciAntonella MessinaPaolo VerderioPaola ColliniAntonino De Paoli

subject

OncologyCancer Researchmedicine.medical_specialtyChemotherapyIfosfamideAnthracyclinebusiness.industrymedicine.medical_treatmentCancerSoft tissueSubgroup analysismedicine.diseaselaw.inventionOncologyRandomized controlled triallawInternal medicinemedicinebusinessAdjuvantmedicine.drug

description

11558Background: We already reported (Cancer 2012;118:5857) the correlation of Choi criteria (Choi) and RECIST with outcome of pts affected by high-risk STS entering a multicentric Italian/Spanish ...

https://doi.org/10.1200/jco.2018.36.15_suppl.11558